Assessment of various psychopharmacological combinations in the treatment of presenile and senile primary degenerative dementia.
The effects of various psychopharmacological combinations were used in a sample of 90 patient fulfilling the DMS-III criteria for presenile or senile primary degenerative dementia divided into 3 equal subgroups. Regardless of the drug combination used, an improvement of verbal test performances was noticed.
Tudorache
B
B
Institute of Neurology and Psychiatry, Bucharest, Romania.
Lupulescu
R
R
Duţan
I
I
Sârbulescu
A
A
D000367:Age Factors; D000368:Aged; D003704:Dementia / Q000188:drug therapy* / Q000453:epidemiology; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D002504:Meclofenoxate / Q000008:administration & dosage; D008875:Middle Aged; D009388:Neostigmine / Q000008:administration & dosage; D010713:Phosphatidylcholines / Q000008:administration & dosage; D010889:Piracetam / Q000008:administration & dosage; D011569:Psychiatric Status Rating Scales; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D012737:Sex Factors
D010713:Phosphatidylcholines; D011619:Psychotropic Drugs; D009388:Neostigmine; D002504:Meclofenoxate; D010889:Piracetam